Tatiana's research involves injecting polilaminina, a substance developed in a laboratory, into patients with spinal cord injuries within 72 hours of trauma, alongside standard decompression surgery, aiming to improve recovery outcomes. The initial pilot project involved eight patients, with one showing significant recovery, five minor improvements, and two fatalities.
Impact: High. This preliminary study offers a glimmer of hope for spinal cord injury patients, but its small sample size and lack of a control group make definitive conclusions about polilaminina's efficacy and safety impossible.
In the source video, this keypoint occurs from 00:46:44 to 00:51:23.
Sources in support: Emílio Garcia (Biologist)

